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In the course of liver cirrhosis the development of portal hypertension is a major 177 driver of complications and therefore a frequent cause of acute decompensations 178 (AD) (1, 2) . AD may lead to a systemic inflammatory response and progress to acute-179 on-chronic liver failure (ACLF), a syndrome with high short-term mortality (3-6). Also 180 in cirrhotic patients, portal hypertension is the driver of spontaneous portosystemic 181 shunts (SPSS) development. 182 The association of SPSS or surgical/interventional shunting with hepatic 183 encephalopathy (HE) is well-known and the first embolizations of SPSS as an option 184 to limit complications of portal hypertension have been reported more than 30 years 185 ago (7-9). However, since then few reports on the role of SPSS in cirrhosis and their 186 possible treatment have been published (10) (11) (12) (13) (14) . A large multicentric study confirmed 187 the association of a single large ( 
373
Validation cohort 374 In the validation cohort clinical but no blood parameters were available at follow up 375 (table 4) . Importantly, the significantly higher rates of episodes of hepatic 376 encephalopathy were confirmed as shown in figure 2b .
377
Large TSA is an independent risk factor for 1-year mortality 378 Training cohort 379 1-year survival data was available in 253 patients. Figure 3a shows Kaplan-Meier Validation cohort 397 In order to validate these results, the validation cohort was stratified for TSA. A total 398 of 312 patients were classified as S-TSA (51%) and 295 as L-TSA (49%). L-TSA 399 patients showed significantly higher MELD and Child-Pugh score. There were no 400 significant differences in type of SPSS between S-TSA and L-TSA patients.
401
Moreover, L-TSA had higher rates of hepatic encephalopathy episodes at baseline 402 and in their medical history (table 4) . Survival data was available in 604 patients. To further investigate the impact of TSA on survival in relation liver function, we 421 divided the whole cohort in tertials according to MELD (6-9, 10-13, 14-40) like in our 422 previous study (15). The rates of 1-year mortality were higher in the L-TSA group and 423 significant in MELD groups 6-9 and 14-40 (supplemental table 10).
424

SPSS and TSA distribution 425
In our recent multicenter study (15), a stratification of patients according to SPSS This situation of multiple SPSS is present in one third of the presented large cohort.
461
The present study demonstrates that the complete shunting volume, which might be SPSS was shown to be associated with bleeding, but no differences between small 487 and large SPSS were detected (7,10,15,29).
Interestingly, the cut-off we found in our patients corresponds to a single shunt of 489 10mm diameter. In non-spontaneous SPSS, such as TIPS, it has been previously 490 shown also that small diameter shunts are associated with less hepatic 491 encephalopathy and survival compared to the usually used 10mm stents (37,38,40).
492
However, in case of TIPS the collaterals and the other SPSS have been rigorously 493 embolized in order to limit TSA to 10mm and other persisting collaterals (in many 494 patients present) may have contributed to non-significant results regarding survival.
495
This study presents a large, multicentric, international, well characterized cohort of (41) (42) (43) (44) (45) . In this study only cirrhotic patients who underwent CT scan were included.
505
This would lead to a selection bias towards patients without severe kidney 506 dysfunction because those patients would not receive CT scan due to contrast media 507 exposure. Moreover, no data on sarcopenia is available, which has recently been 508 recognized as a risk factor for the development of hepatic encephalopathy after TIPS 509 (46-50) and could be a competing factor to consider against TSA.
510
In conclusion, this study for the first time highlights the prognostic importance of TSA
511
(sum of all cross-sectional SPSS areas) in patients with mostly decompensated liver 512 cirrhosis. The prevalence of more than one SPSS among these patients is high and increases with advancement of liver disease. L-TSA is an independent predictor of 1-
514
year mortality and is associated with higher rates of hepatic encephalopathy 515 compared to S-TSA. These data suggest that there is a cut-off for portosystemically 516 shunted blood volume where the beneficial effects get overweighed by the -Total cross-sectional area of spontaneous portosystemic shunt (SPSS), rather than diameter of the single largest SPSS, predicts survival in patients with advanced chronic liver disease.
-The cut-off of the total cross-sectional SPSS area associated with worse survival corresponds to a single shunt of more than 10mm diameter.
-This study may have impact on clinical use of TSA/SPSS for risk stratification and clinical decision-making considering management of SPSS.
